Oncotarget
The cover for issue 59 of Oncotarget features Figure 4, "The expression of AGR2 in metastatic lesions," by Kamal, et al.
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
https://doi.org/10.18632/oncotarget.25764 Lilla Ozgyin, Attila Horvath, and Balint Laszlo Balint |
31312-31329 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process |
https://doi.org/10.18632/oncotarget.25808 Susana Bulnes, Garazi Bermúdez, and José Vicente Lafuente |
31330-31341 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells |
https://doi.org/10.18632/oncotarget.25809 Mamiko Kobayashi, Daisuke Mikami, Junsuke Uwada, Takashi Yazawa, Kazuko Kamiyama, Hideki Kimura, Takanobu Taniguchi, and Masayuki Iwano |
31342-31354 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis |
https://doi.org/10.18632/oncotarget.25823 Roberta Fusco, Ramona D’amico, Marika Cordaro, Enrico Gugliandolo, Rosalba Siracusa, Alessio Filippo Peritore, Rosalia Crupi, Daniela Impellizzeri, Salvatore Cuzzocrea, and Rosanna Di Paola |
31355-31366 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models |
https://doi.org/10.18632/oncotarget.25825 Gabriela Rozic, Lena Paukov, Ziv Cohen, Irit Shapira, Adrian Duek, Ohad Bejamini, Abraham Avigdor, Arnon Nagler, Igor Koman, and Merav Leiba |
31367-31379 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3 |
https://doi.org/10.18632/oncotarget.25826 Giulia Marelli, Roberta Avigni, Paola Allavena, Cecilia Garlanda, Alberto Mantovani, Andrea Doni, and Marco Erreni |
31380-31396 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma |
https://doi.org/10.18632/oncotarget.25829 Daniel Jose García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Rodríguez-Núñez, Guillem Pascual-Pasto, Monica Vila-Ubach, Rosa García-Mejías, María José Robles, Oscar M. Tirado, Jaume Mora, Angel M. Carcaboso, and Enrique de Álava |
31397-31410 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies |
https://doi.org/10.18632/oncotarget.25830 Toshiki Iwai, Masamichi Sugimoto, Daiko Wakita, Keigo Yorozu, Mitsue Kurasawa, and Kaname Yamamoto |
31411-31421 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo |
https://doi.org/10.18632/oncotarget.25831 Yuya Isoda, Wen Piao, Eri Taguchi, Junko Iwano, Shigeki Takaoka, Aiko Uchida, Kiyomi Yoshikawa, Junichi Enokizono, Emi Arakawa, Kazuma Tomizuka, Yasuhisa Shiraishi, and Kazuhiro Masuda |
31422-31431 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
CCL17/TARC and CCR4 expression in Merkel cell carcinoma |
https://doi.org/10.18632/oncotarget.25836 Kashif Rasheed, Ibrahim Abdulsalam, Silje Fismen, Øystein Grimstad, Baldur Sveinbjørnsson, and Ugo Moens |
31432-31447 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer |
https://doi.org/10.18632/oncotarget.25837 Mariko Tsukagoshi, Satoshi Wada, Seiko Hirono, Shintaro Yoshida, Erica Yada, Tetsuro Sasada, Ken Shirabe, Hiroyuki Kuwano, and Hiroki Yamaue |
31448-31458 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
High AGR2 protein is a feature of low grade endometrial cancer cells |
https://doi.org/10.18632/oncotarget.25838 Areege Kamal, Anthony Valentijn, Roger Barraclough, Philip Rudland, Nihad Rahmatalla, Pierre Martin-Hirsch, Helen Stringfellow, Shandya B. Decruze, and Dharani K. Hapangama |
31459-31472 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Press Release | Order a Reprint |
Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma |
https://doi.org/10.18632/oncotarget.25843 Kheshwant S. Gill, Philana Fernandes, Brian Bird, Declan M. Soden, and Patrick F. Forde |
31473-31489 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T |
https://doi.org/10.18632/oncotarget.25844 Jonathan Klein, Wilfred W. Lam, Gregory J. Czarnota, and Greg J. Stanisz |
31490-31501 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content |
https://doi.org/10.18632/oncotarget.25845 Tessa P. Sandberg, Jan Oosting, Gabi W. van Pelt, Wilma E. Mesker, Rob A.E.M. Tollenaar, and Hans Morreau |
31502-31515 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer |
https://doi.org/10.18632/oncotarget.25846 Phuong Thao Nguyen, Dung Nguyen, Chanbora Chea, Mutsumi Miyauchi, Makiko Fujii, and Takashi Takata |
31516-31530 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation |
https://doi.org/10.18632/oncotarget.25847 Taiane Schneider, Arturo Martinez-Martinez, Monica Cubillos-Rojas, Ramon Bartrons, Francesc Ventura, and Jose Luis Rosa |
31531-31548 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells |
https://doi.org/10.18632/oncotarget.25862 Pol Gimenez-Xavier, Eva Pros, Ana Aza, Sebastian Moran, Raul Tonda, Anna Esteve-Codina, Marc Dabad, and Montse Sanchez-Cespedes |
31549-31558 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB |
https://doi.org/10.18632/oncotarget.25943 Po-Hao Feng, Chih-Teng Yu, Kuan-Yuan Chen, Ching-Shan Luo, Shen Ming Wu, Chien-Ying Liu, Lu Wei Kuo, Yao-Fei Chan, Tzu-Tao Chen, Chih-Cheng Chang, Chun-Nin Lee, Hsiao-Chi Chuang, Chiou-Feng Lin, Chia-Li Han, Wei-Hwa Lee, and Kang-Yun Lee |
31559-31559 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC